CEO: Immanuel Lerner 
Year Established: 2011 

Pepticom Ltd. was founded in 2011 to revolutionize the discovery of novel peptide drug candidates using its key asset, an exceptional artificial intelligence platform aimed at designing peptide ligands based upon solved crystal structures that enable Pepticom to operate in various disciplines and generate innovative binding peptides for diverse targets.